investorscraft@gmail.com

Intrinsic ValueiHuman Inc. (IH)

Previous Close$1.84
Intrinsic Value
Upside potential
Previous Close
$1.84

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

iHuman Inc. operates in the rapidly growing edtech sector, specializing in interactive and AI-driven learning solutions for children in China. The company generates revenue primarily through subscription-based access to its digital educational content, which includes gamified learning apps, interactive courses, and personalized learning tools. iHuman has carved a niche by leveraging advanced technologies like artificial intelligence and adaptive learning algorithms to enhance engagement and educational outcomes for young learners. The company competes in a fragmented but high-potential market, where demand for quality digital education is fueled by rising middle-class aspirations and government support for STEM education. iHuman differentiates itself through a strong brand, localized content, and partnerships with educational institutions, positioning it as a trusted provider in China’s burgeoning edtech landscape. Its scalable platform and focus on user retention underscore its potential to capture a larger share of the market as digital adoption accelerates.

Revenue Profitability And Efficiency

In FY 2024, iHuman reported revenue of RMB 922.2 million, reflecting steady demand for its educational offerings. Net income stood at RMB 98.6 million, with diluted EPS of RMB 1.85, indicating healthy profitability. Operating cash flow was RMB 58.5 million, supported by efficient subscription monetization, while capital expenditures of RMB 7.4 million suggest disciplined investment in platform enhancements and content development.

Earnings Power And Capital Efficiency

The company demonstrates solid earnings power, with a net income margin of approximately 10.7%. Its capital-light model is evident in the modest capex relative to revenue, allowing for strong free cash flow generation. The high cash balance of RMB 1.12 billion further underscores efficient capital deployment and liquidity management, providing flexibility for growth initiatives or strategic acquisitions.

Balance Sheet And Financial Health

iHuman maintains a robust balance sheet, with cash and equivalents of RMB 1.12 billion dwarfing total debt of RMB 14.9 million, resulting in a net cash position. This financial strength provides ample cushion for operational needs and strategic investments. The low leverage and high liquidity ratios indicate minimal financial risk, positioning the company favorably for sustained growth.

Growth Trends And Dividend Policy

The company benefits from secular tailwinds in digital education, with growth driven by user acquisition and retention. A dividend of RMB 0.085 per share signals a commitment to shareholder returns, though the payout ratio remains conservative, prioritizing reinvestment in innovation and market expansion. Future growth may hinge on scaling content offerings and penetrating underserved demographics.

Valuation And Market Expectations

Trading at a P/E multiple derived from its RMB 1.85 EPS, iHuman’s valuation reflects market optimism about its growth trajectory in China’s edtech sector. Investors likely price in expectations of sustained subscriber growth and margin stability, though competitive pressures and regulatory scrutiny remain key monitorables.

Strategic Advantages And Outlook

iHuman’s strategic advantages include its first-mover brand recognition, technological edge in adaptive learning, and deep understanding of local educational needs. The outlook remains positive, supported by China’s digital education adoption and the company’s ability to innovate. However, success will depend on maintaining content quality, navigating regulatory frameworks, and expanding its user base efficiently.

Sources

Company filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount